Abbott报告2024年销售增长强劲,但略低于Q4分析员的预期。 Abbott reports strong 2024 sales growth but falls slightly short of Q4 analyst expectations.

Abbott报告2024年强劲销售420亿美元,增长4.6%,有机销售增加9.6%。 Abbott reported strong 2024 sales of $42.0 billion, a 4.6% increase, with organic sales up 9.6%. 尽管第四季度销售额略微少了分析师的预期,但该公司预计2025年有机销售额将增长7.5%至8.5%,每份额的调整收入为5.05至5.25美元。 Despite fourth-quarter sales slightly missing analyst expectations, the company projects 2025 organic sales growth of 7.5% to 8.5% and adjusted earnings per share of $5.05 to $5.25. Abbott的股票在收入报告后在市场前交易中下跌。 Abbott's stock dipped in premarket trading after the earnings report.